These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 22287174)

  • 41. Aβ1-40 and Aβ1-42 Plasmatic Levels In Stroke: Influence of Pre-Existing Cognitive Status and Stroke Characteristics.
    Moulin S; Leys D; Schraen-Maschke S; Bombois S; Mendyk AM; Muhr-Tailleux A; Cordonnier C; Buee L; Pasquier F; Bordet R
    Curr Alzheimer Res; 2017; 14(6):686-694. PubMed ID: 26502812
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adherence-dependent shifts in the patterns of beta-amyloid peptides secreted by human mononuclear phagocytes.
    Maler JM; Spitzer P; Klafki HW; Esselmann H; Bibl M; Lewczuk P; Kornhuber J; Herrmann M; Wiltfang J
    Brain Behav Immun; 2008 Oct; 22(7):1044-1048. PubMed ID: 18511234
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pre-Analytical Sampling and Storage Conditions of Amyloid-β Peptides in Venous and Capillary Blood.
    Walter M; Wiltfang J; Vogelgsang J
    J Alzheimers Dis; 2020; 78(2):529-535. PubMed ID: 33016918
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficient extraction of intact HSA-Aβ peptide complexes from sera: Toward albuminome biomarker identification.
    Rossi E; Tran NT; Hirtz C; Lehmann S; Taverna M
    Talanta; 2020 Aug; 216():121002. PubMed ID: 32456932
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serum Aβ Levels are Associated with Age-related Cataract.
    Li C; Geng Z; Yang B; Xiao H; Wang Z; Ye J
    Neurotox Res; 2021 Apr; 39(2):369-377. PubMed ID: 33400179
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Role of Cathepsin B in the Degradation of Aβ and in the Production of Aβ Peptides Starting With Ala2 in Cultured Astrocytes.
    Oberstein TJ; Utz J; Spitzer P; Klafki HW; Wiltfang J; Lewczuk P; Kornhuber J; Maler JM
    Front Mol Neurosci; 2020; 13():615740. PubMed ID: 33510618
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of Times to Blood Processing on the Stability of Blood Proteins Associated with Dementia.
    Chang JF; Liu HC; Chen HH; Chen WP; Juang JL; Wang PN; Yang SY
    Dement Geriatr Cogn Disord; 2020; 49(3):303-311. PubMed ID: 32784295
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The influence of matrix type, diurnal rhythm and sample collection and processing on the measurement of plasma beta-amyloid isoforms using the INNO-BIA plasma Abeta forms multiplex assay.
    Lachno DR; Vanderstichele H; De Groote G; Kostanjevecki V; De Meyer G; Siemers ER; Willey MB; Bourdage JS; Konrad RJ; Dean RA
    J Nutr Health Aging; 2009 Mar; 13(3):220-5. PubMed ID: 19262957
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association of amyloid-beta with depression or depressive symptoms in older adults without dementia: a systematic review and meta-analysis.
    Twait EL; Wu JH; Kamarioti M; Basten M; van der Flier WM; Gerritsen L; Geerlings MI
    Transl Psychiatry; 2024 Jan; 14(1):25. PubMed ID: 38225253
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An Exploratory Study Provides Insights into MMP9 and Aβ Levels in the Vitreous and Blood across Different Ages and in a Subset of AMD Patients.
    Lynn SA; Soubigou F; Dewing JM; Smith A; Ballingall J; Sass T; Nica I; Watkins C; Gupta B; Almuhtaseb H; Lash SC; Yuen HM; Cree A; Newman TA; Lotery AJ; Ratnayaka JA
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498929
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacokinetics, distribution, and excretion of sodium oligomannate, a recently approved anti-Alzheimer's disease drug in China.
    Lu J; Pan Q; Zhou J; Weng Y; Chen K; Shi L; Zhu G; Chen C; Li L; Geng M; Zhang Z
    J Pharm Anal; 2022 Feb; 12(1):145-155. PubMed ID: 35573885
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bias-generating factors in biofluid amyloid-β measurements for Alzheimer's disease diagnosis.
    Park S; Kim Y
    Biomed Eng Lett; 2021 Nov; 11(4):287-295. PubMed ID: 34616582
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dynamic Blood Concentrations of Aβ
    Yang YH; Huang LC; Hsieh SW; Huang LJ
    Front Cell Dev Biol; 2020; 8():768. PubMed ID: 32850865
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Alterations of aqueous humor Aβ levels in Aβ-infused and transgenic mouse models of Alzheimer disease.
    Kwak DE; Ko T; Koh HS; Ji YW; Shin J; Kim K; Kim HY; Lee HK; Kim Y
    PLoS One; 2020; 15(1):e0227618. PubMed ID: 31923257
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chemically treated plasma Aβ is a potential blood-based biomarker for screening cerebral amyloid deposition.
    Park JC; Han SH; Cho HJ; Byun MS; Yi D; Choe YM; Kang S; Jung ES; Won SJ; Kim EH; Kim YK; Lee DY; Mook-Jung I
    Alzheimers Res Ther; 2017 Mar; 9(1):20. PubMed ID: 28330509
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasma levels of amyloid beta and other proinflammatory mediators in patients with age-related macular degeneration.
    Guymer R; Cipriani T; Rittenhouse KD; Lim L; Robman LD; Li W; Wang W; Deng S; Banerjee P
    Graefes Arch Clin Exp Ophthalmol; 2015 Aug; 253(8):1347-54. PubMed ID: 25744331
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Longitudinal plasma amyloid beta in Alzheimer's disease clinical trials.
    Donohue MC; Moghadam SH; Roe AD; Sun CK; Edland SD; Thomas RG; Petersen RC; Sano M; Galasko D; Aisen PS; Rissman RA
    Alzheimers Dement; 2015 Sep; 11(9):1069-79. PubMed ID: 25301682
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Plasma amyloid beta measurements - a desired but elusive Alzheimer's disease biomarker.
    Toledo JB; Shaw LM; Trojanowski JQ
    Alzheimers Res Ther; 2013; 5(2):8. PubMed ID: 23470128
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Stability of amyloid-β peptides in plasma and serum.
    Bibl M; Welge V; Esselmann H; Wiltfang J
    Electrophoresis; 2012 Feb; 33(3):445-50. PubMed ID: 22287174
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cerebrospinal fluid amyloid beta peptide patterns in Alzheimer's disease patients and nondemented controls depend on sample pretreatment: indication of carrier-mediated epitope masking of amyloid beta peptides.
    Bibl M; Esselmann H; Otto M; Lewczuk P; Cepek L; Rüther E; Kornhuber J; Wiltfang J
    Electrophoresis; 2004 Sep; 25(17):2912-8. PubMed ID: 15349929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.